BIOTIME INC 4
4 · BIOTIME INC · Filed Jul 2, 2014
Insider Transaction Report
Form 4
BIOTIME INCBTX
Bradsher Neal C
10% Owner
Transactions
- Exercise/Conversion
Common Stock
2014-06-30$2.30/sh+20,000$46,000→ 62,908 total - Exercise/Conversion
Option To Purchase Common Shares
2014-06-30−20,000→ 0 totalExercise: $2.30Exp: 2014-07-01→ Common Shares (20,000 underlying)
Holdings
- 20,000
Option to Purchase Common Shares
Exercise: $4.60Exp: 2017-06-30→ Common Shares (20,000 underlying) - 20,000
Option to Purchase Common Shares
Exercise: $5.13Exp: 2016-06-30→ Common Shares (20,000 underlying) - 20,000
Option To Purchase Common Shares
Exercise: $4.13Exp: 2018-06-30→ Common Shares (20,000 underlying) - 13,422,262(indirect: Footnote)
Common Stock
- 20,000
Option to Purchase Common Shares
Exercise: $5.45Exp: 2015-08-09→ Common Shares (20,000 underlying) - 50,000(indirect: Footnote)
Option to Purchase Common Shares
Exercise: $5.00Exp: 2018-06-04→ Common Shares (50,000 underlying)
Footnotes (5)
- [F1]These securities are owned by Neal C. Bradsher, who is a Reporting Person.
- [F2]The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Each of Broadwood Capital, Inc. and Neal C. Bradsher disclaim beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that Broadwood Capital, Inc. or Neal C. Bradsher is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]These options are currently exercisable.
- [F4]These options will vest and become exercisable in four quarterly installments, provided that Neal C. Bradsher remains a director on the last day of each quarter.
- [F5]The options were granted to Neal Bradsher by the issuer on July 2, 2009 as director compensation pursuant to the issuer's 2002 Stock Option Plan, as amended.